Syringe News and Research

RSS

OpEds: Sebelius, Fla. Attorney General, USA Today, Wash Post opine about repeal strategies

Over the past nine months, I've traveled around the country and seen the benefits of this law firsthand. Unless we want to take coverage away from cancer patients, reduce oversight for insurance companies, raise prescription drug costs for seniors, weaken Medicare, add $1 trillion to the deficit and undo dozens of other reforms that are improving health around the country, we can't afford repeal (Kathleen Sebelius, 1/5).

6 Jan 2011

Revolutions Medical reworks exclusive license with Traxyz for breast biopsy localization system

Revolutions Medical Corporation recently completed the reworking of a worldwide exclusive license with Traxyz, LLC for an image guided navigation system to convert over 50,000 conventional mammography systems for use as a high accuracy breast biopsies system (BBS). This BBS facilitates accurate and fast non-palpable lesions and micro calcification localization in the treatment of breast cancer.

4 Jan 2011

PharMEDium introduces pre-labeled, ready-to-use Propofol in tamper evident syringe admixture system

PharMEDium Services LLC, announced the addition of Propofol to its custom operating room anesthesia syringe preparation services. PharMEDium is the first compounder to offer Propofol in a pre-labeled, single patient, ready-to-use, tamper evident syringe admixture system. Healthcare organizations recognize benefits of PharMEDium's prefilled operating room syringes including compliance with regulatory requirements for proper labeling of all medications, and improved economic efficiency by reducing waste.

21 Dec 2010

Smiths Medical launches Medfusion 4000 wireless syringe infusion pump with PharmGuard systems in Canada

Smiths Medical, a leading global medical device manufacturer, announced today it received a license from Health Canada and launched its Medfusion® 4000 syringe infusion pump with the PharmGuard® software suite in Canada. The new customizable system allows health care providers to send and receive medication delivery information more efficiently, helping to prevent medication errors.

15 Dec 2010

Harvard Bioscience files two major patents in regenerative medicine

Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.

From Harvard Bioscience 10 Dec 2010

Medisafe 1 Technologies demonstrates syringe locking device at Israel's National Ministry of Health

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company conducted an official demonstration of its barcoded syringe locking device at Israel's National Ministry of Health.

9 Dec 2010

Audax Medical licenses novel TBL technology to fix broken bones from Brown

Here's the vision: an elderly woman comes into the emergency room after a fall. She has broken her hip. The orthopaedic surgeon doesn't come with metal plates or screws or shiny titanium ball joints. Instead, she pulls out a syringe filled with a new kind of liquid that will solidify in seconds and injects into the break. Over time, new bone tissue will take its place, encouraged by natural growth factors embedded in the synthetic molecules of the material.

8 Dec 2010

Health, HIV and human rights

On World AIDS Day 2010, the global community is focusing attention on protecting human rights of all people affected by HIV.

1 Dec 2010

Medisafe 1 to launch syringe locking device in Jerusalem hospital

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company has engaged in preliminary discussions to launch a pilot of its syringe locking device, with a major hospital in Jerusalem.

30 Nov 2010

To reduce spread of HIV/AIDS, IFRC calls for more focus on IDU programs

Ahead of World AIDS Day, the International Federation of the Red Cross on Friday released a report (.pdf) calling for governments around the world to do more to help stop the spread of HIV/AIDS among populations of injecting drug users (IDUs), the Associated Press reports (Heilprin, 11/25).

30 Nov 2010

Revolutions Medical demonstrates new market samples of 3ml RevVac Safety syringe

Revolutions Medical met with interested global distributors and showed, for the first time, the new market samples of its 3ml RevVac Safety syringe.

24 Nov 2010

Confidisc introduces new anti-illegal drug syringe

ConfiDisc's anti-illegal drug syringe is an integral part of its syringe injection system. The disc, which is attached to the hub of a syringe device, acts as a physical barrier.

22 Nov 2010

Medisafe 1 Technologies to develop new medical locking devices for intravenous administration

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that that the company's board of directors has approved the research and development of two new medical locking device products.

22 Nov 2010

Medisafe 1 presents barcoded syringe locking device at Medica 2010 Conference

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company's exhibition of its barcoded syringe locking device generated overwhelming interest at the annual Medica 2010 Conference in Dusseldorf Germany, held November 16-19.

22 Nov 2010

Inovio achieves positive results in Phase I PENNVAX-B study for HIV

Inovio Pharmaceuticals, Inc. , a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has achieved high vaccine-induced response rates and strong magnitude of immune responses in its Phase I clinical study of PENNVAX-B, a DNA vaccine for the prevention of HIV infection.

18 Nov 2010

Unilife and IMCO enter exclusive marketing program for Unitract range of 1mL safety syringes

Unilife Corporation today announced that it has commenced U.S. sales of its Unitract® range of 1mL safety syringes.

15 Nov 2010

Inovio to update HVTN 080 Phase I clinical study for HIV at HVTN Conference

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.

12 Nov 2010

Ultrasound needle guidance improves performance and outcomes of knee injections

The use of ultrasound needle guidance improves the performance, outcomes and the cost-effectiveness of knee injections in people with osteoarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

9 Nov 2010

Medisafe 1 website highlights ways to prevent incorrect medications

Medisafe 1 Technologies Corp. a developer of patented technologies that physically prevent the unauthorized administration of prescription medications, announced today that the company has uploaded a product presentation on the company's new website.

9 Nov 2010

Revolutions Medical announces completion of designs for 5ml and 10ml fixed needle RevVac Safety Syringes

Revolutions Medical Corporation announced today that due to the launch of its 3ml RevVac Safety SyringeTM during the Medica show in Dusseldorf, Germany and the enormous interest that the launch has received from healthcare professionals and corporations in Europe, the company will host an additional reception in London on Saturday, November 20th from 7:30 PM - 9:30 PM at the Landmark Hotel, Tower Suite.

3 Nov 2010

Syringe News and Research

OpEds: Sebelius, Fla. Attorney General, USA Today, Wash Post opine about repeal strategies

Revolutions Medical reworks exclusive license with Traxyz for breast biopsy localization system

PharMEDium introduces pre-labeled, ready-to-use Propofol in tamper evident syringe admixture system

Smiths Medical launches Medfusion 4000 wireless syringe infusion pump with PharmGuard systems in Canada

Harvard Bioscience files two major patents in regenerative medicine

Medisafe 1 Technologies demonstrates syringe locking device at Israel's National Ministry of Health

Audax Medical licenses novel TBL technology to fix broken bones from Brown

Health, HIV and human rights

Medisafe 1 to launch syringe locking device in Jerusalem hospital

To reduce spread of HIV/AIDS, IFRC calls for more focus on IDU programs

Revolutions Medical demonstrates new market samples of 3ml RevVac Safety syringe

Confidisc introduces new anti-illegal drug syringe

Medisafe 1 Technologies to develop new medical locking devices for intravenous administration

Medisafe 1 presents barcoded syringe locking device at Medica 2010 Conference

Inovio achieves positive results in Phase I PENNVAX-B study for HIV

Unilife and IMCO enter exclusive marketing program for Unitract range of 1mL safety syringes

Inovio to update HVTN 080 Phase I clinical study for HIV at HVTN Conference

Ultrasound needle guidance improves performance and outcomes of knee injections

Medisafe 1 website highlights ways to prevent incorrect medications

Revolutions Medical announces completion of designs for 5ml and 10ml fixed needle RevVac Safety Syringes

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News